Skip to Main Content

Author Details

Gopal Iyer
University of Wisconsin School of Medicine and Public Health, University of Wisconsin
2002
31
16
Leah V Schaffer (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37131583Genomic Analysis of Human Brain Metastases Treated with Stereotactic Radiosurgery Under the Phase-II Clinical Trial (NCT03398694) Reveals DNA Damage Repair at the Peripheral Tumor Edge.medRxiv2023
37873389Targeted inhibition of BET proteins in HPV-16 associated head and neck squamous cell carcinoma reveals heterogeneous transcription response.bioRxiv2023
34763000Next generation in vitro tumor models guiding cancer therapy.Adv Drug Deliv Rev2021
32371583FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer.Mol Cancer Ther2020
31862799<sup>177</sup>Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer.J Nucl Med2020
33283841Winning the Fight Against Cancer.Ann Acad Med Singap2020
32298810Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.Int J Radiat Oncol Biol Phys2020
31067459Defining Reprogramming Checkpoints from Single-Cell Analyses of Induced Pluripotency.Cell Rep2019
29358085Compartmentalization of HP1 Proteins in Pluripotency Acquisition and Maintenance.Stem Cell Reports2018
30108133Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog.Mol Cancer Ther2018
28262749Identification of stable housekeeping genes in response to ionizing radiation in cancer research.Sci Rep2017
26924553Microfluidic enrichment for the single cell analysis of circulating tumor cells.Sci Rep2016
27905891Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab.BMC Cancer2016
27716204Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab.BMC Cancer2016
26162687Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors.Mol Cancer Ther2015
21674354Single-step conjugation of antibodies to quantum dots for labeling cell surface receptors in mammalian cells.Methods Mol Biol2011
21553893Aromatic aldehyde and hydrazine activated peptide coated quantum dots for easy bioconjugation and live cell imaging.Bioconjug Chem2011
20627153Tracking single proteins in live cells using single-chain antibody fragment-fluorescent quantum dot affinity pair.Methods Enzymol2010
19051182Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.Small2009
20018714Fast, background-free, 3D super-resolution optical fluctuation imaging (SOFI).Proc Natl Acad Sci U S A2009
19416475Dynamic partitioning of a glycosyl-phosphatidylinositol-anchored protein in glycosphingolipid-rich microdomains imaged by single-quantum dot tracking.Traffic2009
19053789High affinity scFv-hapten pair as a tool for quantum dot labeling and tracking of single proteins in live cells.Nano Lett2008
17393550Solubilization of quantum dots with a recombinant peptide from Escherichia coli.Small2007
17704240microPET-based biodistribution of quantum dots in living mice.J Nucl Med2007
16318871Advances in fluorescence imaging with quantum dot bio-probes.Biomaterials2006
29151665Near-infrared peptide-coated quantum dots for small animal imaging.Proc SPIE Int Soc Opt Eng2006
17012538VIB-1 is required for expression of genes necessary for programmed cell death in Neurospora crassa.Eukaryot Cell2006
17181021Peptide coated quantum dots for biological applications.IEEE Trans Nanobioscience2006
29176922Peptide-coated semiconductor nanocrystals for biomedical applications.Proc SPIE Int Soc Opt Eng2005
14568157Purification and characterization of laccase from the rice blast fungus, Magnaporthe grisea.FEMS Microbiol Lett2003
12234924Nonself recognition is mediated by HET-C heterocomplex formation during vegetative incompatibility.EMBO J2002
  • 1 - 31 of 31

Recommended Authors

University of Notre Dame
Career Start Year 2015
Number of shared co-authors 0
SRM Institute of Science and Technology
Career Start Year 2012
Number of shared co-authors 0
Ottawa Hospital Research Institute
Career Start Year 2006
Number of shared co-authors 0
Novartis Institutes for Biomedical Research
Career Start Year 2006
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 0
The Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
The University of Texas M.D. Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey
Career Start Year 2003
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 0
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 1
KTH Royal Institute of Technology
Career Start Year 1997
Number of shared co-authors 0
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Yale University
Career Start Year 1996
Number of shared co-authors 0
Beijing Tongren Hospital, Capital Medical University
Career Start Year 1995
Number of shared co-authors 1
University of Tubingen
Career Start Year 1994
Number of shared co-authors 0
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
Dalian University of Technology
Career Start Year 1994
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 1
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
Sichuan University
Career Start Year 1992
Number of shared co-authors 1
University of California San Diego
Career Start Year 1990
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey
Career Start Year 1988
Number of shared co-authors 0
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year 1987
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey
Career Start Year 1983
Number of shared co-authors 0
University of California
Career Start Year 1982
Number of shared co-authors 0
Monash University
Career Start Year 1971
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 0

Collaborators

Institute of Molecular and Cell Biology
Co-authored papers 2
Wisconsin Institute for Discovery, University of Wisconsin-Madison
Co-authored papers 2
University of Wisconsin-Madison
Co-authored papers 2
University of California Berkeley
Co-authored papers 2
Wisconsin Institute for Discovery, University of Wisconsin-Madison
Co-authored papers 2
University of Wisconsin Hospitals and Clinics
Co-authored papers 1
CRUK MRC Oxford Institute for Radiation Oncology, University of Oxford
Co-authored papers 1
Indiana University
Co-authored papers 1
Wisconsin Institute for Discovery, University of Wisconsin-Madison
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of Wisconsin-Madison College of Letters and Sciences
Co-authored papers 1
University of Wisconsin-Madison College of Letters and Sciences
Co-authored papers 1
Wisconsin Institute for Discovery, University of Wisconsin-Madison
Co-authored papers 1
Co-authored papers 1
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 1
University of Wisconsin-Madison
Co-authored papers 1